Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques

Journal of Infectious Diseases

Volumn 199, Issue 1, 2009, Pages 89-96

  Kling, Heather M ^a   Shipley, Timothy W ^a   Patil, Sangita ^a,b   Morris, Alison ^a   Norris, Karen A ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE; ENZYME ANTIBODY; KEXIN; KEXIN ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; DRUG DOSE REDUCTION; FUNGAL COLONIZATION; FUNGUS TRANSMISSION; IMMUNOCOMPETENCE; LUNG LAVAGE; MACACA; MIXED INFECTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PNEUMOCYSTIS; PNEUMOCYSTOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS INFECTION;

ANIMALS; IMMUNOCOMPETENCE; MACACA FASCICULARIS; PNEUMOCYSTIS; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

EID: 58749090934     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/595297     Document Type: Article

References (50)

1. Kaplan JE, Hanson D, Dworkin MS, et al. Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30(Suppl 1):S5-14.
2. Morris A, Lundgren JD, Masur H, et al. Current epidemiology of Pneumocystis pneumonia. Emerg Infect Dis 2004; 10:1713-20.
3. Morris A, Beard CB, Huang L. Update on the epidemiology and transmission of Pneumocystis carinii. Microbes Infect 2002; 4:95-103.
4. Powles MA, McFadden DC, Pittarelli LA, Schmatz DM. Mouse model for Pneumocystis carinii pneumonia that uses natural transmission to initiate infection. Infect Immun 1992; 60:1397-400.
5. Wolff L, Horch S, Gemsa D. The development of Pneumocystis carinii pneumonia in germ-free rats requires immunosuppression and exposure to the Pneumocystis carinii organism. Comp Immunol Microbiol Infect Dis 1993; 16:73-6.
6. Vogel P, Miller CJ, Lowenstine LL, Lackner A. Evidence of horizontal transmission of Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques. J Infect Dis 1993; 168:836-43.
7. Baskin GB, Murphey-Corb M, Watson EA, Martin LN. Necropsy findings in rhesus monkeys experimentally infected with cultured simian immunodeficiency virus (SIV)/delta. Vet Pathol 1988; 25:456-67.
8. Gigliotti F, Garvy BA, Haidaris CG, Harmsen AG. Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice. J Infect Dis 1998; 178:235-42.
9. Harmsen AG, Chen W, Gigliotti F. Active immunity to Pneumocystis carinii reinfection in T-cell-depleted mice. Infect Immun 1995; 63:2391-5.
10. Pascale JM, Shaw MM, Durant PJ, et al. Intranasal immunization confers protection against murine Pneumocystis carinii lung infection. Infect Immun 1999; 67:805-9.
11. Garvy BA, Wiley JA, Gigliotti F, Harmsen AG. Protection against Pneumocystis carinii pneumonia by antibodies generated from either T helper 1 or T helper 2 responses. Infect Immun 1997; 65:5052-6.
12. Gigliotti F, Hughes WT. Passive immunoprophylaxis with specific monoclonal antibody confers partial protection against Pneumocystis carinii pneumonitis in animal models. J Clin Invest 1988; 81:1666-8.
13. Bartlett MS, Angus WC, Shaw MM, et al. Antibody to Pneumocystis carinii protects rats and mice from developing pneumonia. Clin Diagn Lab Immunol 1998; 5:74-7.
14. Gigliotti F, Haidaris CG, Wright TW, Harmsen AG. Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia. Infect Immun 2002; 70:1069-74.
15. Walzer PD. Immunological features of Pneumocystis carinii infection in humans. Clin Diagn Lab Immunol 1999; 6:149-55.
16. Walzer PD. Immunological features of Pneumocystis infection in humans. In: Walzer PD, Cushion MT, eds. Pneumocystis pneumonia. 3rd ed. Vol 194. New York: Marcel Dekker, 2005:451-77.
17. Smulian AG, Sullivan DW, Linke MJ, et al. Geographic variation in the humoral response to Pneumocystis carinii. J Infect Dis 1993; 167:1243-7.
18. Peglow SL, Smulian AG, Linke MJ, et al. Serologic responses to Pneumocystis carinii antigens in health and disease. J Infect Dis 1990; 161:296-306.
19. Lundgren B, Elvin K, Rothman LP, Ljungström I, Lidman C, Lundgren JD. Transmission of Pneumocystis carinii from patients to hospital staff. Thorax 1997; 52:422-4.
20. Wakefield AE, Banerji S, Pixley FJ, Hopkin JM. Molecular probes for the detection of Pneumocystis carinii. Trans R Soc Trop Med Hyg 1990; 84:17-8.
21. Daly KR, Huang L, Morris A, et al. Antibody response to Pneumocystis jirovecii major surface glycoprotein. Emerg Infect Dis 2006; 12:1231-7.
22. Nevez G, Jounieaux V, Linas MD, et al. High frequency of Pneumocystis carinii sp. f. hominis colonization in HIV-negative patients. J Eukaryot Microbiol 1997; 44:36S.
23. Morris A, Kingsley LA, Groner G, Lebedeva IP, Beard CB, Norris KA. Prevalence and clinical predictors of Pneumocystis colonization among HIV-infected men. AIDS 2004; 18:793-8.
24. Medrano FJ, Montes-Cano M, Conde M, et al. Pneumocystis jirovecii in general population. Emerg Infect Dis 2005; 11:245-50.
25. Rabodonirina M, Raffenot D, Cotte L, et al. Rapid detection of Pneumocystis carinii in bronchoalveolar lavage specimens from human immunodeficiency virus-infected patients: use of a simple DNA extraction procedure and nested PCR. J Clin Microbiol 1997; 35:2748-51.
26. Huang L, Crothers K, Morris A, et al. Pneumocystis colonization in HIV-infected patients. J Eukaryot Microbiol 2003;50(Suppl):616-7.
27. Board KF, Patil S, Lebedeva I, et al. Experimental Pneumocystis carinii pneumonia in simian immunodeficiency virus-infected rhesus macaques. J Infect Dis 2003; 187:576-88.
28. Amedee AM, Lacour N, Gierman JL, et al. Genotypic selection of simian immunodeficiency virus in macaque infants infected transplacentally. J Virol 1995; 69:7982-90.
29. Tables of antibacterial drug dosages. In: Pickering LK, ed. Red Book: 2003 Report of the Committee on Infectious Diseases. 26th ed. Vol 2003. Elk Grove Village, IL: American Academy of Pediatrics, 2003:699-712.
30. Norris KA, Morris A, Patil S, Fernandes E. Pneumocystis colonization, airway inflammation, and pulmonary function decline in acquired immunodeficiency syndrome. Immunol Res 2006; 36:175-87.
31. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60:532-8.
32. Croix DA, Board K, Capuano S 3rd, et al. Alterations in T lymphocyte profiles of bronchoalveolar lavage fluid from SIV-and Pneumocystis carinii-coinfected rhesus macaques. AIDS Res Hum Retroviruses 2002; 18:391-401.
33. Patil SP, Board KF, Lebedeva IP, Norris KA. Immune responses to Pneumocystis colonization and infection in a simian model of AIDS. J Eukaryot Microbiol 2003; 50:661-2.
34. Savoia D, Millesimo M, Cassetta I, Forno B, Caramello P. Detection of Pneumocystis carinii by DNA amplification in human immunodeficiency virus-positive patients. Diagn Microbiol Infect Dis 1997; 29:61-5.
35. Kutty G, Kovacs JA. A single-copy gene encodes Kex1, a serine endoprotease of Pneumocystis jiroveci. Infect Immun 2003; 71:571-4.
36. Lee LH, Gigliotti F, Wright TW, Simpson-Haidaris PJ, Weinberg GA, Haidaris CG. Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 2000; 242:141-50.
37. Lugli EB, Allen AG, Wakefield AE. A Pneumocystis carinii multi-gene family with homology to subtilisin-like serine proteases. Microbiology 1997; 143:2223-36.
38. Kovacs JA, Powell F, Edman JC, et al. Multiple genes encode the major surface glycoprotein of Pneumocystis carinii. J Biol Chem 1993; 268:6034-40.
39. Smulian AG, Keely SP, Sunkin SM, Stringer JR. Genetic and antigenic variation in Pneumocystis carinii organisms: tools for examining the epidemiology and pathogenesis of infection. J Lab Clin Med 1997; 130:461-8.
40. + T cell-independent DNA vaccination against opportunistic infections. J Clin Invest 2005; 115:3536-44.
41. Wells J, Haidaris CG, Wright TW, Gigliotti F. Active immunization against Pneumocystis carinii with a recombinant P. carinii antigen. Infect Immun 2006; 74:2446-8.
42. Daly KR, Fichtenbaum CJ, Tanaka R, et al. Serologic responses to epitopes of the major surface glycoprotein of Pneumocystis jiroveci differ in human immunodeficiency virus-infected and uninfected persons. J Infect Dis 2002; 186:644-51.
43. Gigliotti F, Harmsen AG, Wright TW. Characterization of transmission of Pneumocystis carinii f. sp. muris through immunocompetent BALB/c mice. Infect Immun 2003; 71:3852-6.
44. An CL, Gigliotti F, Harmsen AG. Exposure of immunocompetent adult mice to Pneumocystis carinii f. sp. muris by cohousing: growth of P. carinii f. sp. muris and host immune response. Infect Immun 2003; 71:2065-70.
45. Baskerville A, Dowsett AB, Cook RW, Dennis MJ, Cranage MP, Greenaway PJ. Pneumocystis carinii pneumonia in simian immunodeficiency virus infection: immunohistological and scanning and transmission electron microscopical studies. J Pathol 1991; 164:175-84.
46. Yanai T, Simon MA, Doddy FD, Mansfield KG, Pauley D, Lackner AA. Nodular Pneumocystis carinii pneumonia in SIV-infected macaques. Vet Pathol 1999; 36:471-4.
47. Furuta T, Fujita M, Mukai R, et al. Severe pulmonary pneumocystosis in simian acquired immunodeficiency syndrome induced by simian immunodeficiency virus: its characterization by the polymerase-chain-reaction method and failure of experimental transmission to immunodeficient animals. Parasitol Res 1993; 79:624-8.
48. Empey KM, Hollifield M, Schuer K, Gigliotti F, Garvy BA. Passive immunization of neonatal mice against Pneumocystis carinii f. sp. muris enhances control of infection without stimulating inflammation. Infect Immun 2004; 72:6211-20.
49. Gigliotti F, Wiley JA, Harmsen AG. Immunization with Pneumocystis carinii gpA is immunogenic but not protective in a mouse model of P. carinii pneumonia. Infect Immun 1998; 66:3179-82.
50. Theus SA, Smulian AG, Steele P, Linke MJ, Walzer PD. Immunization with the major surface glycoprotein of Pneumocystis carinii elicits a protective response. Vaccine 1998; 16:1149-57.